Notes on a Condition #4, 2019

Notes on a Condition #4, 2019

Goldin+Senneby

Nine-part graphic story on the experience of participating in a Phase III clinical trial of the drug Gilenya, which is the first pill for the treatment of MS. The active substance of the medicine has been extracted from a parasitic fungus that feeds on cicada nymphs and grows out through their heads.

Notes on a Condition #4, 2019